Anna Vyazovaya senior researcher and Daria Starkova researcher of the Laboratory of Molecular Epidemiology and Evolutionary Genetics took part in the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) in Madrid (Spain) from 21st till 24th of April, 2018.
Almost 13 thousand researchers from 128 countries took part in the Congress of the largest scientific society in the field of clinical microbiology and infectious diseases. 3563 of 5500 abstracts were accepted and published. There were more than 150 oral presentations on infectious diseases and clinical microbiology at the Congress, including eight keynote lectures, more than 100 symposia and oral sessions, 22 educational workshops and 22 meet-the-expert sessions.
The following areas were discussed at the Congress: viral infection and diseases (HIV / AIDS, viral hepatitis, influenza and respiratory viruses, emerging/reemerging and zoonotic viral diseases, antiviral drugs, treatment, susceptibility/resistance, molecular epidemiology, diagnosis), bacterial infection and diseases (tuberculosis and other mycobacterial infections, respiratory infections, gastrointestinal and other infections), drug sensitivity and resistance (mechanisms, methods), diagnosis, new antibacterial drugs, immunology and vaccination, etc.
Within the session Tuberculosis: from pathogenesis to patient management Anna Vyazovaya and Daria Starkova presented a poster Mycobacterium tuberculosis Beijing genotype clonal complexes in the Russian borderline regions with EU (the research was carried out with the support of the Russian Science Foundation). The results of their own research in the field of molecular epidemiology of M.tuberculosis were discussed with the participants from Spain, France, Poland and Sweden.
The Scientific Programme ECCMID 2018 is available on the official site: http://www.eccmid.org/scientific_programme/
